- Home
- SSYS vs PCRX Comparison
SSYS vs PCRX Comparison
Compare SSYS & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSYS
- PCRX
- Stock Information
- Founded
- SSYS 1989
- PCRX 2006
- Country
- SSYS United States
- PCRX United States
- Employees
- SSYS N/A
- PCRX N/A
- Industry
- SSYS Computer peripheral equipment
- PCRX Biotechnology: Pharmaceutical Preparations
- Sector
- SSYS Technology
- PCRX Health Care
- Exchange
- SSYS Nasdaq
- PCRX Nasdaq
- Market Cap
- SSYS 634.6M
- PCRX 604.7M
- IPO Year
- SSYS 1994
- PCRX 2011
- Fundamental
- Price
- SSYS $9.32
- PCRX $22.45
- Analyst Decision
- SSYS Strong Buy
- PCRX Buy
- Analyst Count
- SSYS 4
- PCRX 10
- Target Price
- SSYS $11.50
- PCRX $27.60
- AVG Volume (30 Days)
- SSYS 453.2K
- PCRX 821.8K
- Earning Date
- SSYS 03-06-2025
- PCRX 02-27-2025
- Dividend Yield
- SSYS N/A
- PCRX N/A
- EPS Growth
- SSYS N/A
- PCRX N/A
- EPS
- SSYS N/A
- PCRX N/A
- Revenue
- SSYS $578,436,000.00
- PCRX $694,957,000.00
- Revenue This Year
- SSYS N/A
- PCRX $4.83
- Revenue Next Year
- SSYS $3.22
- PCRX $2.16
- P/E Ratio
- SSYS N/A
- PCRX N/A
- Revenue Growth
- SSYS N/A
- PCRX 4.40
- 52 Week Low
- SSYS $6.05
- PCRX $11.16
- 52 Week High
- SSYS $14.01
- PCRX $34.01
- Technical
- Relative Strength Index (RSI)
- SSYS 52.15
- PCRX 68.72
- Support Level
- SSYS $8.36
- PCRX $18.18
- Resistance Level
- SSYS $9.10
- PCRX $22.36
- Average True Range (ATR)
- SSYS 0.47
- PCRX 1.17
- MACD
- SSYS 0.03
- PCRX 0.31
- Stochastic Oscillator
- SSYS 70.07
- PCRX 88.61
About SSYS Stratasys Ltd. (Israel)
Stratasys Ltd is a polymer-based 3D printing solution, which provides a product life cycle, with multiple technologies and complete solutions for superior application fit, across industrial, healthcare, and consumer fields. It focuses, in particular, on polymer 3D printing solutions that address the fastest-growing manufacturing solutions viewed as the potential growth opportunity in the 3D printing industry. Its printers include FDM, PolyJet, Stereolithography, P3, and SAF. Its software is GrabCAD Software, Connectivity, Digital Anatomy Creator, and OpenAM Software. It generates revenue through 3D printing systems, related services, and consumables and by providing additive manufacturing solutions.
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.